ZICHEM PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ZICHEM PHARMA
Largest movements
- Receivables within one year +€31,838
up €31,838 (+7.1%), from €451,125 to €482,963
of which Other amounts receivable: +€28,180
- Stocks and contracts +€10,686
up €10,686 (+12.6%), from €84,993 to €95,679
- Tangible fixed assets -€6,340
down €6,340 (-13.9%), from €45,740 to €39,400
- Reserves +€40,263
up €40,263 (+8.2%), from €490,877 to €531,140
- Gross operating margin +€21,824
up €21,824 (+71.8%), from €30,401 to €52,225
- Taxes +€5,416
up €5,416 (+67.6%), from €8,013 to €13,429
- Depreciation -€3,083
down €3,083 (-32.7%), from €9,423 to €6,340
- Financial income -€2,844
down €2,844 (-21.6%), from €13,186 to €10,342
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €587,672 | €622,406 | +€34,734 | +5.9% |
| Fixed assets | 21/28 | €45,985 | €39,645 | -€6,340 | -13.8% |
| Intangible fixed assets | 21 | €0 | €0 | = | |
| Tangible fixed assets | 22/27 | €45,740 | €39,400 | -€6,340 | -13.9% |
| Land and buildings | 22 | €31,732 | €29,856 | -€1,876 | -5.9% |
| Plant, machinery and equipment | 23 | €7,832 | €5,193 | -€2,638 | -33.7% |
| Furniture and vehicles | 24 | €6,176 | €4,351 | -€1,825 | -29.6% |
| Financial fixed assets | 28 | €245 | €245 | = | 0.0% |
| Current assets | 29/58 | €541,688 | €582,761 | +€41,074 | +7.6% |
| Stocks and contracts in progress | 3 | €84,993 | €95,679 | +€10,686 | +12.6% |
| Stocks | 30/36 | €84,993 | €95,679 | +€10,686 | +12.6% |
| Amounts receivable within one year | 40/41 | €451,125 | €482,963 | +€31,838 | +7.1% |
| Trade receivables | 40 | €109,066 | €112,724 | +€3,658 | +3.4% |
| Other amounts receivable | 41 | €342,059 | €370,239 | +€28,180 | +8.2% |
| Cash at bank and in hand | 54/58 | €5,569 | €4,119 | -€1,450 | -26.0% |
| Total equity and liabilities | 10/49 | €587,672 | €622,406 | +€34,734 | +5.9% |
| Equity | 10/15 | €497,983 | €538,245 | +€40,263 | +8.1% |
| Contributions | 10/11 | €7,105 | €7,105 | = | 0.0% |
| Reserves | 13 | €490,877 | €531,140 | +€40,263 | +8.2% |
| Distributable reserves | 133 | €490,877 | €531,140 | +€40,263 | +8.2% |
| Amounts payable | 17/49 | €89,690 | €84,161 | -€5,529 | -6.2% |
| Amounts payable within one year | 42/48 | €89,690 | €84,161 | -€5,529 | -6.2% |
| Trade debts | 44 | €86,332 | €80,732 | -€5,600 | -6.5% |
| Suppliers | 440/4 | €86,332 | €80,732 | -€5,600 | -6.5% |
| Taxes, remuneration and social security | 45 | €3,358 | €3,429 | +€71 | +2.1% |
| Taxes | 450/3 | €3,358 | €3,429 | +€71 | +2.1% |
| Remuneration, social security and pensions | 62 | €101 | €360 | +€259 | +256% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €9,423 | €6,340 | -€3,083 | -32.7% |
| Other operating charges | 640/8 | €1,651 | €1,699 | +€48 | +2.9% |
| Gross operating margin | 9900 | €30,401 | €52,225 | +€21,824 | +71.8% |
| Operating profit (loss) | 9901 | €19,226 | €43,827 | +€24,601 | +128% |
| Financial income | 75/76B | €13,186 | €10,342 | -€2,844 | -21.6% |
| Recurring financial income | 75 | €13,186 | €10,342 | -€2,844 | -21.6% |
| Financial charges | 65/66B | €421 | €478 | +€56 | +13.4% |
| Recurring financial charges | 65 | €421 | €478 | +€56 | +13.4% |
| Profit (loss) for the period before taxes | 9903 | €31,991 | €53,692 | +€21,701 | +67.8% |
| Income taxes | 67/77 | €8,013 | €13,429 | +€5,416 | +67.6% |
| Profit (loss) for the period | 9904 | €23,978 | €40,263 | +€16,285 | +67.9% |
| Profit (loss) for the period to be appropriated | 9905 | €23,978 | €40,263 | +€16,285 | +67.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.